LY3971297
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
November 19, 2025
A Study of LY3971297 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=225 | Recruiting | Sponsor: Eli Lilly and Company | Trial completion date: Dec 2025 ➔ Sep 2026 | Trial primary completion date: Dec 2025 ➔ Sep 2026
Trial completion date • Trial primary completion date • Cardiovascular • Genetic Disorders • Hypertension • Obesity
June 27, 2025
A Study of LY3971297 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=225 | Recruiting | Sponsor: Eli Lilly and Company | Trial completion date: Jun 2025 ➔ Dec 2025 | Trial primary completion date: Jun 2025 ➔ Dec 2025
Trial completion date • Trial primary completion date • Cardiovascular • Genetic Disorders • Hypertension • Obesity
October 29, 2024
A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension
(clinicaltrials.gov)
- P1 | N=225 | Recruiting | Sponsor: Eli Lilly and Company | Trial completion date: Feb 2025 ➔ Jun 2025 | Trial primary completion date: Feb 2025 ➔ Jun 2025
Trial completion date • Trial primary completion date • Cardiovascular • Genetic Disorders • Hypertension • Obesity
August 01, 2024
A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension
(clinicaltrials.gov)
- P1 | N=188 | Recruiting | Sponsor: Eli Lilly and Company | Trial primary completion date: Oct 2024 ➔ Feb 2025
Trial primary completion date • Cardiovascular • Genetic Disorders • Hypertension • Obesity
January 05, 2024
A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension
(clinicaltrials.gov)
- P1 | N=188 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiovascular • Genetic Disorders • Hypertension • Obesity
1 to 5
Of
5
Go to page
1